HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes

Diabetes Care

Volumn 30, Issue 10, 2007, Pages 2706-2707

  Groop, Per Henrik ^a,b,e   Thomas, Merlin C ^c   Rosengård Bärlund, Milla ^a,b   Mills, Vashti ^d   Rönnback, Mats ^a,b   Thomas, Stephen ^d   Forsblom, Carol ^a,b   Taskinen, Maria Rita ^b   Viberti, Giancarlo ^d  

^a FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d GUY S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; STROKE;

EID: 35148821004     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc07-0030     Document Type: Article

References (13)

1. Maser RE, Wolfson SK Jr, Ellis D, et al: Cardiovascular disease and arterial calcification in insulin-dependent diabetes mellitus: interrelations and risk factor profiles: Pittsburgh Epidemiology of Diabetes Complications Study-V. Arterioscler Thromb 11:958-965, 1991
2. Koivisto VA, Stevens LK, Mattock M, et al.: Cardiovascular disease and its risk factors in IDDM in Europe: EURODIAB IDDM Complications Study Group. Diabetes Care 19:689-697, 1996
3. Groop PH, Viberti GC, Elliott TG, et al.: Lipoprotein(a) in type 1 diabetic patients with renal disease. Diabet Med 11:961-967, 1994
4. Thomas MC, Rosengard-Barlund M, Mills V, et al.: Serum lipids and the progression of nephropathy in type 1 diabetes. Diabetes Care 29:317-322, 2006
5. Groop PH, Elliott T, Ekstrand A, et al.: Multiple lipoprotein abnormalities in type 1 diabetic patients with renal disease. Diabetes 45:974-979, 1996
6. Lahdenpera S, Groop PH, Tilly-Kiesi M, et al.: LDL subclasses in IDDM patients: relation to diabetic nephropathy. Diabetologia 37:681-688, 1994
7. Mühlhauser I, Sawicki PT, Blank M, et al.: Reliability of causes of death in persons with type I diabetes. Diabetologia 45:1490-1497, 2002
8. Taskinen MR: Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes 41 (Suppl 2):12-17, 1992
9. Peynet J, Guillausseau PJ, Legrand A, et al.: Serum LpAI lipoprotein particles in diabetic patients with and without renal lesions of different grades. Diabet Metab 19:355-360, 1993
10. Cheung MC, Albers JJ: Characterization of lipoprotein particles isolated by immunoaffinity chromatography: particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem 259:12201-12209, 1984
11. Puchois P, Kandoussi A, Fievet P: Apolipoprotein A-I containing lipoproteins in coronary heart disease. Atherosclerosis 68:35-40, 1987
12. Parra HJ, Arveiler D, Evans AE, et al: A case-control study of lipoprotein particles in two populations at contrasting risk for coronary heart disease: the ECTIM Study. Arterioscler Thromb 12:701-707, 1992
13. Luc G, Bard JM, Ferrieres J, et al.: Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study: Prospective Epidemiological Study of Myocardial Infarction. Arterioscler Thromb Vasc Biol 22:1155-1161, 2002